In this issue:
- Electronic alerts and care bundle for AKI
- Effects of aspirin on CV outcomes in CKD
- SARS-COV-2 vaccine does not trigger new-onset glomerulonephritis
- Personalised cooler dialysate for maintenance haemodialysis
- RAAS inhibition in advanced CKD
- Empagliflozin for CKD
- Diabetes management in CKD
- Lifetime benefit of RAAS + SGLT-2 inhibitors in nondiabetic albuminuric CKD
- Correlates and consequences of acute eGFR change in response to dapagliflozin for CKD
- Kidney-function trajectories from young adulthood to midlife
Please login below to download this issue (PDF)